Comparative in vitro activity of nine antistaphylococcal agents against 275 recent isolates of Gram-positive cocci

被引:4
|
作者
Ravaoarinoro, M
Therrien, C
机构
[1] HOSP HOTEL DIEU,DEPT MICROBIOL & INFECT DIS,MONTREAL,PQ,CANADA
[2] UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL,PQ H3C 3J7,CANADA
关键词
in vitro activity; antimicrobial agents; Gram positive cocci; RESISTANT STAPHYLOCOCCUS-AUREUS; TEICHOMYCETICUS-NOV-SP; TEICOPLANIN; ENTEROCOCCI; VANCOMYCIN;
D O I
10.1016/S0924-8579(96)00317-2
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The aim of this study was to compare the in vitro activities of 9 antistaphylococcal agents including teicoplanin (TEI) against 275 non-repetitive clinical strains representing 15 species of staphylococci and 27 strains of Enterococcus (E.) faecalis, isolated from various specimens between 1991-1992 at a Canadian teaching hospital. The NCCLS agar dilution method was used (10(4) colony-forming units/spot). In terms of MIC(90), TEI and vancomycin (VAN) appeared to be the most potent antibiotics against all staphylococci tested (TEI: 2.0-4.0 mu g/ml; VAN: 1.0-2.0 mu g/ml; ciprofloxacin (CPF): 0.25-32 mu g/ml; cefazolin (CEF): 8.0-256 mu g/ml; methicillin (MET): 2.0->256 mu g/ml; imipenem (IMP): 1.0-32 mu g/ml; erythromycin (ERT): 16->256 mu g/ml; ampicillin (AMP): 16-128 mu g/ml; fusidic acid (FSA): 0.5-16 mu g/ml). Multiple resistant strains, including MET-resistant Staphylococcus (Staph.) aureus and Staph. epidermidis, were susceptible to TEI and VAN with respective MICs of 2-4 mu g/ml and 1-2 mu g/ml regardless of specimen type. Moreover, TEI was highly active against E. faecalis (MIC(90) for TEI and VAN: 0.5 and 4.0 mu g/ml, respectively).
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [1] In vitro activity of teicoplanin against gram-positive cocci
    Allouch, P
    Pina, P
    Chaplain, C
    Delarbre, JM
    Geffroy, F
    Grasmick, CP
    Marcolin, M
    Morel, A
    Pangon, B
    Rio, Y
    Sédaillan, A
    PATHOLOGIE BIOLOGIE, 2000, 48 (08): : 792 - 795
  • [2] Comparative in vitro activity of ceftobiprole against Gram-positive cocci
    Betriu, Carmen
    Culebras, Esther
    Gomez, Maria
    Lopez-Fabal, Fatima
    Rodriguez-Avial, Iciar
    Picazo, Juan J.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2010, 36 (02) : 111 - 113
  • [3] In vitro activity of telavancin and comparators against selected groups of Gram-positive cocci
    Hope, Russell
    Chaudhry, Aiysha
    Adkin, Rachael
    Livermore, David M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (03) : 213 - 217
  • [4] Nationwide surveillance in Taiwan of the in-vitro activity of tigecycline against clinical isolates of Gram-positive cocci
    Tsao, Shih-Ming
    Lin, Hsiu-Chen
    Lee, Chun-Ming
    Hsu, Gwo-Jong
    Chen, Chih-Ming
    Sun, Wu
    Liu, Yung-Ching
    Jang, Tsrang-Neng
    Cheng, Yu-Jen
    Lu, Po-Liang
    Chiang, Ping-Chreng
    Wang, Lih-Shinn
    Kung, Hsiang-Chi
    Chuang, Yin-Ching
    Shi, Zhi-Yuan
    Liu, Jien-Wei
    Huang, Cheng-Hua
    Lu, Chin-Te
    Liao, Chun-Hsing
    Hsueh, Po-Ren
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 : S184 - S187
  • [5] In vitro activity of tigecycline against Gram-positive cocci:: a multicentre study in Greece
    Malli, E.
    Spiliopoulou, I.
    Kolonitsiou, F.
    Neocleous, Ch.
    Klapsa, D.
    Pantelidi, K.
    Panopoulou, M.
    Grapsa, S.
    Alepopoulou, E.
    Neonakis, I.
    Alexiou-Daniel, S.
    Bakola, D.
    Koutsia-Carouzou, C.
    Malamou-Lada, H.
    Zerva, L.
    Vlahaki, E.
    Kartali-Ktenidou, S.
    Anastassiou, E.
    Petinaki, E.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (05) : 1158 - 1160
  • [6] INVITRO ACTIVITY OF VANCOMYCIN AND TEICOPLANIN ON GRAM-POSITIVE COCCI
    BEZIAN, MC
    RIBOU, G
    MASQUELIER, B
    PATHOLOGIE BIOLOGIE, 1992, 40 (05): : 461 - 465
  • [7] Comparative in vitro activity of gemifloxacin against gram-positive and gram-negative clinical isolates in Argentina
    Lopez, H
    Stepanik, D
    Vilches, V
    Scarano, S
    Sarachian, B
    Mikaelian, G
    Finlay, J
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2001, 40 (04) : 187 - 192
  • [8] In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece
    Malli, E.
    Spiliopoulou, I.
    Kolonitsiou, F.
    Klapsa, D.
    Giannitsioti, E.
    Pantelidi, K.
    Pratti, A.
    Panopoulou, M.
    Grapsa, S.
    Alepopoulou, E.
    Neonakis, I.
    Frantzidou, F.
    Alexiou-Daniel, S.
    Bakola, D.
    Koutsia-Carouzou, C.
    Malamou-Lada, H.
    Zerva, L.
    Vlahaki, E.
    Kartali-Ktenidou, S.
    Anastassiou, E. D.
    Petinaki, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (06) : 525 - 528
  • [9] Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16
    Pfaller, Michael A.
    Mendes, Rodrigo E.
    Duncan, Leonard R.
    Flamm, Robert K.
    Sader, Helio S.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (10) : 2748 - 2756
  • [10] Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates
    Sader, Helio S.
    Fritsche, Thomas R.
    Jones, Ronald N.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (05) : 2171 - 2175